Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy

Published:2003-03 Issue:5 Volume:39 Page:631-634
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Park K,Kim J,Lim S,Han S

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. p185, a product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity;Stern;Moll. Cell. Biol.,1986

2. Human breast cancer;Slamon;Science,1987

3. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project;Paik;J. Clin. Oncol.,1990

4. Prognostic significance of HER-2 oncoprotein expression in breast cancer;Toikkanen;J. Clin. Oncol.,1992

5. erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer;Paik;J. Natl. Cancer Inst.,1998

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the potent TOPO IIα inhibitors in breast cancer through the study of computational drug discovery research approaches;Molecular Diversity;2024-05-21

2. Spatially selective cell treatment and collection for integrative drug testing using hydrodynamic flow focusing and shifting;PLOS ONE;2023-01-17

3. Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients;Journal of Oncology;2020-11-28

4. Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer;Breast Cancer;2020-08-11

5. Progress of Individualized Chemotherapy for Gastric Carcinoma Under the Guidance of Genetic Testing;Current Medicinal Chemistry;2020-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3